BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Business

  Ascendancy Healthcare Announces Distribution Partnership With EffRx

  November 4, 2013

   · 

  1 min read
• Drug Development

  Merck & Co., Inc.’s Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-Cancers Caused by Five Additional HPV Types, in Phase 3 Study

  November 4, 2013

   · 

  1 min read
• Drug Development

  Enlivex Therapeutics Ltd. Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients

  November 4, 2013

   · 

  2 min read
• Policy

  CureMark Begins NDA Submission for CM-AT Autism Treatment

  November 4, 2013

   · 

  2 min read
• Business

  arGEN-X and de Duve Institute at the Catholique University of Louvain to Collaborate on Novel Immunomodulation Therapy in Cancer

  November 4, 2013

   · 

  3 min read
• BioCapital

  Spherix Announces Private Placement as the Company Continues to Execute Its Patent Monetization Program - Spherix accepts $2.0 Million from Investors

  November 4, 2013

   · 

  3 min read
• Business

  Juvenile Diabetes Research FoundationTeams Up With Pfizer Inc.'s Centers for Therapeutic Innovation to Support Novel Translational Research in Type 1 Diabetes

  November 4, 2013

   · 

  2 min read
• Drug Development

  Auris Medical AG Reaches Special Protocol Assessment Agreement With FDA for Pivotal Phase III Clinical Trial With AM-101 in Treatment of Acute Peripheral Tinnitus

  November 4, 2013

   · 

  3 min read
• Drug Development

  Active Biotech AB’s Partner Teva Pharmaceutical Industries Limited Initiates a Further Clinical Trial in Multiple Sclerosis

  November 4, 2013

   · 

  1 min read
• Business

  Merck Serono and Kadimastem Sign Memorandum of Understanding (MOU) on Drug Screening and Discovery for Neurodegenerative Diseases

  November 4, 2013

   · 

  4 min read